序贯诱导治疗急性早幼粒细胞白血病长期生存分析
被引量:1
Long-term survival analysis of acute promyelocytic leukemia treated with sequential induction chemotherapy
摘要
近年来急性早幼粒细胞白血病(APL)的分子学发病机制逐渐被阐明,其治疗经历了蒽环类药物为主的联合化疗、全反式维甲酸(ATRA)和亚砷酸(ATO)治疗3个阶段。
出处
《临床血液学杂志》
CAS
2013年第3期331-333,共3页
Journal of Clinical Hematology
参考文献16
-
1FENAUX P,CASTAIGNE S,DOMBRET H,et al.All-tranvS retinoic acid followed by intensive chemo-therapy gives a high complete remission rate and mayprolong remissions in newly diagnosed acute promye-locytic leukemia:a pilot study on 26 cases[J]. Blood,1992,80:2176-2181.
-
2全反式维甲酸治疗544例急性早幼粒细胞白血病的临床研究[J].中华血液学杂志,1992,13(3):135-137. 被引量:94
-
3MUINDI J,FRANKEL S R, MILLER WH Jr,et al.Continuous treatment with all-trans retinoic acid cau-ses a progressive reduction in plasma drug concentra-tions: implications for relap'se and retinoid “ resist-ance” in patients with acute promyelocytic leukemia[J]. Blood,1992,79:299-303.
-
4HUANG C UDENG M L,GUO R J,et al. A studyon the induction of differentiation of human leukemiccelLs by harringtonine combined with cytarabine[J].Leukemia, 1988,2:518 — 522.
-
5FENAUX P,CASTAIGNE S,CHOMIENNE C,et al.All tranvS retinoic acid treatment for patients with a-cute promyelocytic leukemia [ J ]. Leukemia, 1992,6Suppl 1 :64 — 66.
-
6SANZ M A,LO COCO F, MARTIN G,et al. Defini-tion of relapse risk and role of nonanthracycline drugsfor consolidation in patients with acute promyelocyticleukemia: A joint study of the PETHEMA andG1MEMA cooperative groups [J]. Blood, 2000 , 96:1247-1253.
-
7PARK J H,QIAO B,PANAGEAS K S,et al. Earlydeath rate in acute promyelocytic leukemia remainshigh despite all-trans retinoic acid [ J]. Blood, 2011,118:1248—1254.
-
8MONTESINOS P,BERGUA J M,VEILENGA E,etal. Differentiation syndrome in patients with acutepromyelocytic leukemia treated with all-trans retinoicacid and anthracycline chemotherapy: characteristics,outcome,and prognostic factors[J]. Blood,2009,113 :775-783.
-
9黄昌亮,郝森量.小剂量三尖杉酯碱阿糖胞苷联合治疗急非淋白血病的疗效预测[J].中华血液学杂志,1991,12(8):430-431. 被引量:2
-
10梁英民.佟瑞芝,黄昌亮.三尖杉酯碱与阿糖胞苷在诱导HL-60细胞分化中的协同作用[J].中华血液学杂志,1992,13(3):144-144.
二级参考文献12
-
1Burnett AK, Milligan D, Prentice AG, et al. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. Cancer, 2007, 109: 1114-1124.
-
2Huang CL, Deng ML, Guo R J, et al. A study on the induction of differentiation of human leukemic ceils by harringtonine combined with cytarabine. Leukemia, 1988, 2:518-522.
-
3Kantarjian HM, Talpaz M, Santini V, et al. Homoharringtonine: history, current research, and future direction. Cancer, 2001, 92: 1591-1605.
-
4Boyd AW, Sullivan JR. Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug Harringtonine. Blood, 1984, 63: 384-392.
-
5Latagliata R, Breccia M, Pulsoni A, et al. Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs induction. Leuk Lymphoma, 2000, 36: 539-541.
-
6Rizzieri DA, O'Brien JA, Broadwater G, et al.Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia. Cancer, 2009, 115: 2922-2929.
-
7Fernandez HF, Sun Z, Yao X, et al. Anthracycline dose intensification in acute myeloid leukemia. N EngI J Med, 2009, 361: 1249-1259.
-
8Mayer R J, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med, 1994, 331: 896-903.
-
9卞寿庚,中华内科杂志,1990年,20卷,22页
-
10陈子兴,中华血液学杂志,1990年,11卷,121页
共引文献95
-
1闫晓婷,郭梦金,耿涛,张晓芳,刘志远,胡美琴,柴永红,张红柏.生脉注射液影响急性早幼粒细胞白血病预后的临床研究[J].陕西中医,2008,29(10):1319-1321. 被引量:4
-
2冯雅青,贺永春,李跃,吴继颖,郭晔,张立东,章宏涛,张彦芳.全反式维甲酸联合三氧化二砷治疗急性早幼粒细胞白血病的疗效观察[J].临床血液学杂志,2004,17(5):294-294. 被引量:2
-
3李栋.亚砷酸、全反式维甲酸与化疗药物综合治疗急性早幼粒细胞白血病12例[J].白血病.淋巴瘤,2004,13(4):225-226.
-
4李志军,伍国顺,李爱珠.小剂量三氧化二砷联合化疗治疗血液恶性肿瘤的临床疗效观察[J].广西医学,2004,26(9):1312-1313. 被引量:3
-
5周新强.维甲酸和砷剂与联合化疗交替治疗急性早幼粒细胞白血病15例分析[J].中国误诊学杂志,2004,4(3):451-452. 被引量:3
-
6李光霞.儿童急性早幼粒细胞白血病2例分析[J].中国误诊学杂志,2004,4(3):453-454.
-
7王晓红,任洪军,柴静媛.三氧化二砷治疗复发性急性早幼粒细胞白血病临床观察[J].中国医科大学学报,2004,33(6):571-571.
-
8席亚明,陆晓茜,王镜.全反式维甲酸与三氧化二砷治疗急性早幼粒细胞白血病临床分析[J].临床血液学杂志,2005,18(2):109-110. 被引量:8
-
9卢立志,王文英.全反式维甲酸治疗急性早幼粒细胞白血病现状及相关若干问题[J].现代诊断与治疗,2005,16(2):127-128. 被引量:15
-
10荆凌华,刘松年,阮林海,郭艳珍.全反式维甲酸联合三氧化二砷治疗初发急性早幼粒细胞白血病的疗效观察[J].国外医学(内科学分册),2005,32(6):265-268. 被引量:1
同被引文献2
-
1马荣军,朱尊民,袁晓莉,姜丽,杨世伟,杨靖,郭建民,时杰,雷平冲,张琳,商宝军,孙恺,翟亚萍,李威,张茵.成人急性早幼粒细胞白血病预后相关因素分析[J].中华血液学杂志,2017,38(7):592-596. 被引量:12
-
2中华医学会血液学分会,中国医师协会血液科医师分会,沈志祥,黄晓军,马军.中国急性早幼粒细胞白血病诊疗指南(2018年版)[J].中华血液学杂志,2018,39(3):179-183. 被引量:199
引证文献1
-
1李国辉,范玉贞,陈任安,秦炜炜,及月茹,刘聪,周柰岑,陈怡,郭怀鹏,刘利.三氧化二砷治疗急性早幼粒细胞白血病患者的疗效及预后分析[J].国际输血及血液学杂志,2019,42(4):296-304. 被引量:6
二级引证文献6
-
1宋登鹏,吴胜英.雷公藤红素对人急性早幼粒白血病荷瘤模型小鼠黏附分子及细胞周期的影响[J].中国实验血液学杂志,2021,29(1):72-76. 被引量:4
-
2鲁会卿.三氧化二砷治疗急性早幼粒细胞白血病患者的临床效果[J].临床医学研究与实践,2021,6(25):94-96. 被引量:2
-
3李秀琴.阿维A胶囊和三氧化二砷联合蒽环类药物对初发急性早幼粒细胞白血病29例血常规及凝血指标的影响[J].药品评价,2022,19(3):162-165. 被引量:2
-
4史瑞,温静,吴雯,宋艳萍,雷小茹.全反式维甲酸联合砷剂序贯治疗成人APL患者的疗效[J].医学临床研究,2022,39(9):1315-1317.
-
5胡丹,陈倩.急性早幼粒细胞白血病患者经全反式维甲酸、三氧化二砷联合治疗后短期死亡的危险因素分析[J].临床医学研究与实践,2023,8(5):28-31.
-
6郭小朋.全反式维甲酸+三氧化二砷联合整体护理治疗急性早幼粒细胞性白血病的临床疗效观察[J].临床研究,2023,31(7):170-173. 被引量:2
-
1黎国屏.乳腺癌治疗现状[J].河北医药,2002,24(5):403-404. 被引量:8
-
2崔龙.直肠癌术后复发的预防与再手术[J].中华胃肠外科杂志,2009,12(3):226-228. 被引量:2
-
3丽桥.五年抗癌求医攻略之一:异地求医[J].中国家庭医生,2011(11):55-55.
-
4龙健.为癌症立传[J].科学新闻,2013(3):15-15.
-
5吕光明,钟南保.原发性肝癌的放射治疗进展[J].实用肝脏病杂志,2011,14(3):238-240. 被引量:1
-
6马春雷,王国英.乳腺癌的分子生物学发病机制[J].内蒙古医学杂志,2009,41(S3):33-37. 被引量:2
-
7唐安球,周华富.食管癌治疗现状及进展[J].医学综述,2014,20(1):39-41. 被引量:45
-
8李玉亮,王永正,崔允峰.支气管动脉化学栓塞治疗肺癌进展[J].中国中西医结合影像学杂志,2003,1(1):61-63.
-
9李志华,姜庆.前哨淋巴结活检在乳腺癌外科治疗中的应用[J].现代医药卫生,2009,25(11):1678-1680.
-
10文冬.想陪你吃顿早餐[J].中外健康文摘,2008,5(23):59-59.